Impact of Commissural Misalignment on Hydrodynamic Function Following Valve-in-Valve Intervention With the ACURATE neo

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • David Meier
  • Mariama Akodad
  • Andrew G. Chatfield
  • Georg Lutter
  • Thomas Puehler
  • Søndergaard, Lars
  • David A. Wood
  • John G. Webb
  • Stephanie L. Sellers
  • Janarthanan Sathananthan

Background: Limited evidence is available regarding valve-in-valve (VIV) intervention with the ACURATE neo transcatheter heart valve (THV). Low implantation has demonstrated leaflet interaction between the surgical bioprosthesis and the THV, leading to impaired hydrodynamic performance. It is unknown if commissural alignment (CA) can affect this phenomenon. Novel techniques have now been developed to achieve CA with the ACURATE neo THV. Objectives: The aim of this study was to assess the impact of commissural misalignment (CMA) on hydrodynamic function following VIV intervention with the ACURATE neo THV using a bench model. Methods: VIV intervention was performed with the ACURATE neo (a self-expanding THV with supra-annular leaflet position) implanted deep in the surgical bioprosthetic aortic valve (Mitroflow). Hydrodynamic function at CA (0°) and 3 different degrees of CMA (30°, 60°, and 90°) was tested. As per the International Organization for Standardization, a regurgitant fraction <20% is considered optimal. Results: Following VIV, the central THV regurgitant fraction at 0°, 30°, 60°, and 90° of CMA was 8.6% ± 2.0%, 30.3% ± 12.0%, 42.6% ± 11.9%, and 66.7% ± 25.4% (P < 0.0001), respectively. On high-speed video there was no evidence of leaflet interaction at CA, whereas at 30°, 60°, and 90° of CMA there was clear evidence of THV leaflet interaction with those of the surgical valve, leading to impaired leaflet closure and to severe central THV regurgitation. Conclusions: In VIV using the ACURATE neo THV at deep implantation, increasing degree of CMA was associated with THV leaflet interaction with those of the surgical valve and worsening regurgitant fraction. THV leaflet interaction was prevented when there was CA.

OriginalsprogEngelsk
TidsskriftJACC: Cardiovascular Interventions
Vol/bind15
Udgave nummer15
Sider (fra-til)1532-1539
ISSN1936-8798
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Dr Meier is supported by the Swiss National Science Foundation (grant P2LAP3_199561). Dr Akodad has received research funding from Medtronic, Biotronik, MUSE Explore, and Federation Française de Cardiologie. Dr Chatfield is funded by the New Zealand Heart Foundation and John Ormiston Scholarship. Dr Lutter is a consultant to Edwards Lifesciences, Medtronic, and Abbott. Puehler is a consultant to Abbott. Dr Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. Dr Sathananthan is a consultant to Edwards Lifesciences, Medtronic, and Boston Scientific; and has received research funding from Edwards Lifesciences and Medtronic. Dr Søndergaard has received consulting fees and/or institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and SMT. Dr Wood is a consultant to and has received research funding from Edwards Lifesciences and Abbott. Dr Sellers is a consultant for Edwards Lifesciences and Medtronic.

Publisher Copyright:
© 2022 American College of Cardiology Foundation

ID: 327323822